Lazard Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,753,445
| Closed | -$2.52M | – | 1920 |
|
|
2020
Q3 | $2.52M | Buy |
1,753,445
+997,103
| +132% | +$1.44M | ﹤0.01% | 694 |
|
|
2020
Q2 | $1.51M | Buy |
+756,342
| New | +$1.51M | ﹤0.01% | 715 |
|
|
2020
Q1 | – | Sell |
-5,600
| Closed | -$23K | – | 1665 |
|
|
2019
Q4 | $23K | Buy |
+5,600
| New | +$23K | ﹤0.01% | 1201 |
|
|
2019
Q1 | – | Sell |
-45,200
| Closed | -$300K | – | 1181 |
|
|
2018
Q4 | $300K | Buy |
+45,200
| New | +$300K | ﹤0.01% | 833 |
|
|
2016
Q2 | – | Sell |
-147,384
| Closed | -$1.76M | – | 1078 |
|
|
2016
Q1 | $1.76M | Buy |
147,384
+21,426
| +17% | +$256K | ﹤0.01% | 620 |
|
|
2015
Q4 | $1.68M | Buy |
125,958
+119,458
| +1,838% | +$1.59M | ﹤0.01% | 644 |
|
|
2015
Q3 | $69K | Buy |
+6,500
| New | +$69K | ﹤0.01% | 900 |
|